Skip to main content
Premium Trial:

Request an Annual Quote

Jackson Lab Wins $25M for Mouse Genome Database

NEW YORK (GenomeWeb News) – The Jackson Laboratory has netted a $25.2 million grant from the National Human Genome Research Institute to support its Mouse Genome Database (MGD), an open-source resource for researchers studying human disease and biology around the world.

The institute in Bar Harbor, Me., said the funds include a $24.6 million grant and a $500,000 supplement to provide continued funding for the MGD, which provides genome-scale data sets for mouse and human, cross-references mouse genetic information with physiological data, and standardizes the vocabulary for diseases, genes, and physical characteristics.

The NHGRI funding will support salaries for three dozen researchers working on the MGD and development of new online tools to enhance the database's querying functions. It also will provide for staff for technical assistance and training for those using the database.

The MGD houses information on genetic markers, phenotypes, sequences, mapping data, distribution patterns for recombinant inbred strains, cross haplotypes, and a range of other types of information.

That data is pulled from scientific literature, DNA mapping panel data, the Massachusetts Institute of Technology's Whitehead Institute, Washington University, the IMAGE Consortium, and from various researchers.

"The goal of MGD is to facilitate use of the mouse and to enable development of new hypotheses for new discoveries in human medicine," Jackson Professor Janan Eppig, a co-principal investigator on the grant, said in a statement. "We will continue to make all data in MGD freely available to all."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.